Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

ConclusionThis real-world multinational data  set showed that most patients withEGFRm+  aNSCLC were treated per the country relevant clinical guidelines, with progression as the main reason for early treatment discontinuation. For the included countries, these findings may offer a useful benchmark for decision makers to determine future allocation of healthcare resources for patient s withEGFRm+  aNSCLC.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research